Regeneron Pharmaceuticals Logo

Regeneron Pharmaceuticals

🇺🇸
REGN
US75886F1075

Regeneron Pharmaceuticals is a leading US-based biopharmaceutical company that researches, develops, and markets innovative medicines. It focuses on improving the health of patients with serious diseases through scientific discoveries in areas such as oncology, immunology, and ophthalmology.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
Pre-Market
In 63 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will Regeneron Pharmaceuticals report its next quarterly earnings?

Regeneron Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Regeneron Pharmaceuticals last report quarterly earnings?

Regeneron Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 14.29 USD.

How does Regeneron Pharmaceuticals stock react to earnings?

Across its last 5 earnings reports, Regeneron Pharmaceuticals stock moved by ±6% on average the following day. The largest reaction was +11.8% on 10/28/2025; 3 of 5 reactions were positive.

How often has Regeneron Pharmaceuticals beaten expectations?

Regeneron Pharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Regeneron Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$16.00
Actual:
Q2 2026
Beat
Estimate:$10.16
Actual:$14.29
Difference:+$4.13
Price reaction (1 day):+6.2 %
Price reaction (7 days):+11.0 %
Q1 2026
Beat
Estimate:$8.91
Actual:$9.47
Difference:+$0.56
Price reaction (1 day):-6.2 %
Price reaction (7 days):-1.5 %
Q4 2025
Beat
Estimate:$10.74
Actual:$11.44
Difference:+$0.70
Price reaction (1 day):-1.1 %
Price reaction (7 days):+4.8 %
Q3 2025
Beat
Estimate:$9.64
Actual:$11.83
Difference:+$2.19
Price reaction (1 day):+11.8 %
Price reaction (7 days):+7.3 %
Q1 2025
Beat
Estimate:$8.44
Actual:$12.89
Difference:+$4.45
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+4.5 %
Price reaction (7 days):-0.2 %

Earnings statistics

Stock reaction to earnings

±6%
Avg. next-day move
+11.8%
Largest move (10/28/2025)
60%
Share of positive reactions
±5%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+10.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Regeneron Pharmaceuticals
Ticker Symbol
REGN
ISIN
US75886F1075
Country
🇺🇸
USA
Sector
Index membership